Improved conditioned avoidance learning by oxytocin administration in high-emotional male Sprague-Dawley rats

Regulatory Peptides

Volumn 88, Issue 1-3, 2000, Pages 27-32

  Uvnaäs Moberg, Kerstin ^a   Eklund, Malin ^a   Hillegaart, Viveka ^a   Ahlenius, Sven ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Conditioned avoidance; Learning; Oxytocin; Rat; Stress

Indexed keywords

OXYTOCIN; OXYTOCIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG EFFECT; EMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

ANIMALS; AVOIDANCE LEARNING; EMOTIONS; ESCAPE REACTION; MALE; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0342514746     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(99)00112-3     Document Type: Article

References (30)

1. Arletti R., Bertolini A. Oxytocin acts as an antidepressant in two animal models of depression. Life Sci. 41:1987;1725-1730.
2. Barden N., Reul J.M., Holsboer F. Do antidepressants stabilize mood through action on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci. 18:1995;6-11.
3. Breton C., Zingg H.H. Expression and region-specific regulation of the oxytocin receptor gene in rat brain. Endocrinology. 138:1997;1857-1862.
4. de Wied D., Diamant M., Fodor M. Central nervous system effects of neurohypophysial hormones and related peptides. Frontiers Neuroendocrinol. 14:1993;251-302.
5. Ermisch A., Barth T., Ruhle H.J., Skopkova J., Hrbas P.O., Landgraf R. On the blood-brain barrier to peptides: accumulation of labeled vasopressin, DesGlyNH2 vasopressin and oxytocin by brain regions. Endocrinol Exp. 19:1985;29-37.
6. Feifel D., Reza T. Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating. Psychopharmacology. 141:1999;93-98.
7. Frasch A., Zetzsche T., Steiger A., Jirikowski G.F. Reduction of plasma oxytocin levels in patients suffering from major depression. Adv Exp Med Biol. 395:1995;257-258.
8. Gibbs D.M. Vasopressin and oxytocin: hypothalamic modulators of the stress response: A review. Psychoneuroendocrinology. 11:1986;131-140.
9. Heinrichs S.C. Stress-axis, coping and dementia: gene-manipulation studies. Trends Pharmacol Sci. 20:1999;311-315.
10. Hindmarch I. Cognition and anxiety: the cognitive effects of anti-anxiety medication. Acta Psych Scand. 393:(Suppl.):1998;89-94.
11. Hollander M., Wolfe D.A. Nonparametric Statistical Methods. 1973;Wiley, New York.
12. Kremarik P., Freund-Mercier M.J., Stoeckel M.E. Oxytocin and vasopressin binding sites in the hypothalamus of the rat: histoautoradiographic detection. Brain Res Bull. 36:1995;195-203.
13. Legros J.-J., Chiodera P., Geenen V. Inhibitory action of exogenous oxytocin in plasma cortisol in normal human subjects: Evidence of action at the adrenal level. Neuroendocrinology. 48:1988;204-206.
14. McEwen B.S. Protective and damaging effects of stress mediators. New Engl J Med. 338:1998;171-179.
15. Perry W., Geyer M.A., Braff D.L. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch Gen Psychiat. 56:1999;277-282.
16. Petersson M., Alster P., Lundeberg T., Uvnäs-Moberg K. Oxytocin causes a long-term decrease of blood pressure in female and male rats. Physiol Behav. 60:1996;1311-1315.
17. Petersson M., Alster P., Lundeberg T., Uvnäs-Moberg K. Oxytocin increases nociceptive thresholds in a long-term perspective in female and male rats. Neurosci Lett. 212:1996;87-90.
18. Petersson M., Hulting A.-L., Uvnäs-Moberg K. Oxytocin causes a sustained decrease in plasma levels of corticosterone in rats. Neurosci Lett. 264:1999;41-44.
19. Robbins T.W., Elliott R., Sahakian B.J. Neuropsychology - dementia and affective disorders. Br Med Bull. 52:1996;627-643.
20. Rosenstein L.D. Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s. Neuropsychol Rev. 8:1998;109-167.
21. Salmi P., Samuelsson J., Ahlenius S. A new computer-assisted two-way avoidance conditioning equipment for rats: behavioural and pharmacological validation. J Pharmacol Toxicol Meth. 32:1994;155-159.
22. Tribollet E. Vasopressin and oxytocin receptors in the rat brain. Björklund A., Hökfelt T. Handbook of Chemical Neuroanatomy. 1992;289-320 Elsevier, New York.
23. Uvnäs-Moberg K. Oxytocin may mediate the benefits of positive social interaction and emotions. Psychoneuroendocrinology. 23:1998;819-825.
24. Uvnäs-Moberg K. Antistress pattern induced by oxytocin. News Physiol Sci. 13:1998;22-26.
25. Uvnäs-Moberg K., Ahlenius S., Hillegaart V., Alster P. High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol Biochem Behav. 49:1994;101-106.
26. Uvnäs-Moberg K., Alster P., Hillegaart V., Ahlenius S. Oxytocin reduces exploratory motor behaviour and shifts the activity towards the center of the arena in male rats. Acta Physiol Scand. 145:1992;429-430.
27. Uvnäs-Moberg K., Björkstrand E., Hillegaart V., Ahlenius S. Oxytocin as a possible mediator of SSRI-induced antidepressant effects. Psychopharmacology. 142:1999;95-101.
28. Uvnäs-Moberg K., Björkstrand E., Salmi P., Johansson C., Åstrand M., Ahlenius S. Endocrine and behavioral traits in low-avoidance Sprague-Dawley rats. Regulatory Pept. 80:1999;75-82.
29. Windle R.J., Shanks N., Lightman S.L., Ingram C.D. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology. 138:1997;2829-2834.
30. Yoshimura R., Kiyama H., Kimura T., et al. Localization of oxytocin receptor messenger ribonucleic acid in the rat brain. Endocrinology. 133:1993;1239-1246.